Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis ...

Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this ...

Investigators studied trends in the drug survival of adalimumab over time, with regard to the addition of new biologics available for psoriasis.

The United States leads the world in pharmaceutical innovation, with research and development expenditures of over $103 ...

Alvotech () has held its Q1 earnings call. Read on for the main highlights of the call. Meet Samuel – Your Personal Investing Prophet. Start a conversation with TipRanks’ trus ...

Unlock Value in This Generic Drug Gem; Alvotech (NASDAQ:ALVO) Chief Strategy Officer Balaji Prasad said the biosimilar developer is preparing to resubm ...

Trump is expected to announce an expansion of TrumpRx’s offerings as the administration intensifies its push to lower ...

Rising Oncology Cases, Patent Expirations of Blockbuster Biologics, and Strategic Collaborations Among Leading Biopharma ...

The gap between US drug prices and those abroad is not a market outcome — it is the result of deliberate political and ...

Samsung Bioepis touts Adalloce data improving quality of life, confirming safety in Korea Poster data at KCR 2026 highlight ...

At the time of filing this report, the stock of the Bangalore-based company was trading at Rs 240.10 apiece on the BSE, down ...